A Phase 2 Randomized Double-Blind Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects with Eosinophilic Esophagitis- TEST

Recruiting
99 years or below
All
Phase
N/A
1 Location
Brief description of study
TBD
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 845034